Vireo Growth (VREOF) Amortization - Intangibles (2020 - 2026)
Vireo Growth's (VREOF) quarterly Amortization - Intangibles came in at $2.7 million in Q1 2026, up 1250.0% year-on-year from $200000.0 in Q1 2025, and down 18.75% quarter-over-quarter from $3.3 million in Q4 2025.
Vireo Growth (VREOF) Amortization - Intangibles (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Amortization - Intangibles across 7 years of filings, most recently posting $2.7 million for Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $2.7 million, up 1250.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.3 million (up 1017.09% YoY), and the FY2025 annual result was $5.7 million, up 698.14% from the prior year.
- Amortization - Intangibles came in at $2.7 million for Q1 2026 at Vireo Growth, down from $3.3 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $3.3 million in Q4 2025 to a low of $159028.0 in Q2 2023.
- The 5-year median for Amortization - Intangibles is $180033.0 (2023), against an average of $620187.1.
- Across the five-year window, Amortization - Intangibles fell 19.26% in 2022 and surged 1745.81% in 2025, its largest moves.
- Vireo Growth's Amortization - Intangibles stood at $159766.0 in 2022, then grew by 12.69% to $180033.0 in 2023, then changed by 0.0% to $180033.0 in 2024, then soared by 1745.81% to $3.3 million in 2025, then fell by 18.75% to $2.7 million in 2026.
- The last three Amortization - Intangibles figures came in at $2.7 million (Q1 2026), $3.3 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 3.32 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 714,323.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 180,033.00 |
| Sep 30, 2024 | 180,034.00 |
| Jun 30, 2024 | 180,033.00 |
| Mar 31, 2024 | 180,034.00 |
| Dec 31, 2023 | 180,033.00 |
| Sep 30, 2023 | 180,034.00 |
| Jun 30, 2023 | 159,028.00 |
| Mar 31, 2023 | 159,766.00 |
| Dec 31, 2022 | 159,766.00 |
| Sep 30, 2022 | 172,267.00 |
| Jun 30, 2022 | 172,267.00 |
| Mar 31, 2022 | 172,267.00 |
| Dec 31, 2021 | 197,888.00 |
| Sep 30, 2021 | 206,442.00 |
| Jun 30, 2021 | 206,442.00 |